Atom | PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)

Due Dates: September 5, 2024 | January 5, 2025 | April 5, 2025 | September 5, 2025

Funding Amounts: Phase I: up to $306,872 (1 year) | Phase II: up to $2,045,816 (2 years); higher budgets possible for select topics

Summary: Supports US small businesses collaborating with research institutions to develop and commercialize innovative health-related technologies; clinical trials are not allowed.

Key Information: Only US small businesses are eligible; foreign organizations cannot apply; see topic-specific budget limits and requirements.

PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)

Sign in to see full grant listing